|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
+0.14% | +29.68% |
| 2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
| 2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Stallergenes Greer plc announced that Fereydoun Firouz has decided to retire at the end of the year, Mr. Meister has been elected to become Chairman of the Board, and Michele Antonelli will become Chief Executive Officer.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.68% | 0 | |
| +9.28% | 8.74B | |
| -14.24% | 4.94B | |
| +49.95% | 4.7B | |
| +5.96% | 3.98B | |
| -23.57% | 2.28B | |
| +16.29% | 2.28B | |
| +17.77% | 2.14B | |
| -32.28% | 2.12B | |
| -0.50% | 1.64B |
STALLERGENES GREER 
